Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

OTRA

OTR Acquisition (OTRA)

OTR Acquisition Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:OTRA
DataHoraFonteTítuloCódigoCompanhia
13/02/202315:45Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OTRAOTR Acquisition Corporation
31/05/202209:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:OTRAOTR Acquisition Corporation
20/05/202217:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OTRAOTR Acquisition Corporation
20/05/202209:00Business WireComera Life Sciences Debuts as Publicly Traded Company Focused on Transforming BiologicsNASDAQ:OTRAOTR Acquisition Corporation
19/05/202217:08Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:OTRAOTR Acquisition Corporation
18/05/202210:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OTRAOTR Acquisition Corporation
17/05/202210:55Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:OTRAOTR Acquisition Corporation
13/05/202217:36Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OTRAOTR Acquisition Corporation
13/05/202208:17Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:OTRAOTR Acquisition Corporation
09/05/202209:00Business WireComera Life Sciences Announces Research Collaboration with Top 10 Pharmaceutical Company to Develop Subcutaneous FormulationNASDAQ:OTRAOTR Acquisition Corporation
27/04/202209:00Business WireComera Life Sciences to Present at 18th Annual PEGS Boston Conference & ExpoNASDAQ:OTRAOTR Acquisition Corporation
19/04/202209:00Business WireComera Life Sciences and Intas Pharmaceuticals Announce Research CollaborationNASDAQ:OTRAOTR Acquisition Corporation
18/04/202209:00Business WireComera Life Sciences and OTR Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business CombinationNASDAQ:OTRAOTR Acquisition Corporation
15/04/202213:05Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:OTRAOTR Acquisition Corporation
08/03/202218:08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OTRAOTR Acquisition Corporation
08/03/202218:02Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:OTRAOTR Acquisition Corporation
18/02/202218:38Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OTRAOTR Acquisition Corporation
04/02/202210:00Business WireOTR Acquisition Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business CombinationNASDAQ:OTRAOTR Acquisition Corporation
31/01/202210:32Business WireComera Life Sciences to Become Publicly Traded via Business Combination with OTR Acquisition Corp.NASDAQ:OTRAOTR Acquisition Corporation
06/08/202117:16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OTRAOTR Acquisition Corporation
17/05/202117:11Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:OTRAOTR Acquisition Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:OTRA